1. Home
  2. CCSI vs IRWD Comparison

CCSI vs IRWD Comparison

Compare CCSI & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Consensus Cloud Solutions Inc.

CCSI

Consensus Cloud Solutions Inc.

HOLD

Current Price

$26.40

Market Cap

561.4M

Sector

Technology

ML Signal

HOLD

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

HOLD

Current Price

$4.33

Market Cap

526.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCSI
IRWD
Founded
2021
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
561.4M
526.7M
IPO Year
2022
2009

Fundamental Metrics

Financial Performance
Metric
CCSI
IRWD
Price
$26.40
$4.33
Analyst Decision
Strong Buy
Buy
Analyst Count
2
3
Target Price
$37.50
$7.67
AVG Volume (30 Days)
107.2K
1.9M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1400.00
EPS
4.35
0.15
Revenue
$349,696,000.00
$298,276,000.00
Revenue This Year
$3.33
$57.95
Revenue Next Year
$2.70
$4.39
P/E Ratio
$5.85
$29.13
Revenue Growth
N/A
8.88
52 Week Low
$17.84
$0.55
52 Week High
$31.67
$5.78

Technical Indicators

Market Signals
Indicator
CCSI
IRWD
Relative Strength Index (RSI) 53.21 66.15
Support Level $25.07 $3.07
Resistance Level $26.62 $5.67
Average True Range (ATR) 1.04 0.23
MACD 0.21 0.13
Stochastic Oscillator 94.63 91.00

Price Performance

Historical Comparison
CCSI
IRWD

About CCSI Consensus Cloud Solutions Inc.

Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in fax cloud business. The Company operates in USA, Canada, Ireland, and Other. Geographically, it derives a maximum revenue from the United States. The company's communication and digital signature solutions enable customers to securely and cooperatively access, exchange and use information across organizational, regional, and national boundaries.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.

Share on Social Networks: